Breaking News, Collaborations & Alliances

Quotient Sciences Partners with Emplicure to Manufacture and Study EMPLI03

Emplicure is developing EMPLI03 as an oral buccal tablet with extended-release properties intended for the treatment of moderate to severe pain.

Author Image

By: Charlie Sternberg

Associate Editor

Quotient Sciences, a global drug development and manufacturing accelerator, has partnered with Emplicure, a Swedish pharmaceutical company focused on chronic pain and abuse-deterrent formulations.   The partnership will see Quotient Sciences support the GMP manufacture and first clinical pharmacokinetic (PK) study for EMPLI03 using its unique Translational Pharmaceutics platform.   Emplicure is developing EMPLI03 as an oral buccal tablet with extended-release properties intended for the trea...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters